Efficacy and Safety Outcomes with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Type 1 Diabetes According to Glycemic Variability-ONWARDS 6 Post Hoc Analysis

被引：0
|
作者：
Irace, Concetta
Begtrup, Kamilla
Marques, Mariana Fragao
Watt, Sara K.
Klonoff, David C.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1882-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1882-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials
    Abuelazm, Mohamed
    Ibrahim, Ahmed A.
    Khlidj, Yehya
    Badr, Amr
    Amin, Ahmed Mazen
    Elzeftawy, Mohamad A.
    Gowaily, Ibrahim
    Elsaeidy, Ahmed Saad
    Abdelazeem, Basel
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (02)
  • [32] Once-weekly insulin icodec and hospitalisation: insights from the ONWARDS 1-6 trials
    Philis-Tsimikas, A.
    Bache, J. K.
    Bari, T. J.
    Salvesen-Sykes, K.
    Kellerer, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S401 - S401
  • [33] Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
    Russell-Jones, David
    Babazono, Tetsuya
    Cailleteau, Roman
    Engberg, Susanne
    Irace, Concetta
    Kjaersgaard, Maiken Ina Siegismund
    Mathieu, Chantal
    Rosenstock, Julio
    Woo, Vincent
    Klonoff, David C.
    LANCET, 2023, 402 (10413): : 1636 - 1647
  • [34] Once-weekly insulin icodec: pharmacokinetic and pharmacodynamic properties in type 1 diabetes
    Hoevelmann, U.
    Engberg, S.
    Heise, T.
    Kristensen, N. R.
    Norgreen, L.
    Ribel-Madsen, R.
    Zijlstra, E.
    Haahr, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S399 - S400
  • [35] CGM-based parameters for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-naive patients with type 2 diabetes
    Lingvay, I.
    Bang, R. Beck
    Liu, L.
    Mader, J.
    Pettus, J.
    Wagner, L.
    Mathieu, C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 265 - 266
  • [36] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
  • [37] Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
    Ribeiro e Silva, Rodrigo
    Gauza, Mateus de Miranda
    Schramm Guisso, Maria Eduarda
    Nunes da Silva, Julia Opolski
    Kohara, Suely Keiko
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (05):
  • [38] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [39] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
  • [40] Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D
    Svehlikova, Eva
    Arfelt, Kristine Niss
    Cailleteau, Roman
    Deller, Sigrid
    Thomsen, Karen Margrete
    Hart, Marlies
    Mursic, Ines
    Pieber, Thomas
    Haahr, Hanne
    DIABETES, 2022, 71
12345